A nationwide registry study confirmed that there was a marginally significant reduction of MI and coronary death with OAC plus clopidogrel compared to triple therapy in AF patients after myocardial infarction or PCI.
← all excerpts
Optimal antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary intervention: triple therapy is too much!
1
—
—